#IDIBELLfellows: Romina Miranda / Marta Valle

07/10/2020 15:00-16:00

Room 205 – Nou aulari UB-Bellvitge
Microsoft Teams Meeting

#IDIBELLconnect: Novel clinical and translational research approaches to mesothelioma, an orphan tumor

Ernest Nadal

Group Leader at Bellvitge Biomedical Research Institute (IDIBELL), Clinical Research in Solid Tumors Group, Oncobell Program
Head of Section of Thoracic, Brain and Head and Neck Tumors, Catalan Institute of Oncology (ICO), Department of Medical Oncology
Associate Professor, University of Barcelona, Department of Clinical Sciences, Campus Bellvitge

09/10/2020 13:00-14:00

Microsoft Teams Meeting

Career Day 2020

21/10/2020 -

21-22 October 2020
This event is being held online

La recerca en temps de pandèmia

Dra. Maria Ángeles Domínguez
Dr. Xavier Solanich

21/10/2020 19:00-

VII Programa de excelencia en el abordaje del paciente con EM de alta actividad

Unitat EM HUB

22/10/2020 -

22-23 Octubre 2020

Sala d’actes Bellvitge University hospital 9.00h

#IDIBELLconnect: RANK a novel therapeutic target in breast cancer

Speaker Eva Gonzalez-Suarez

Transformation and Metastasis Group, Oncobell Program

06/11/2020 13:00-14:00

PhD Day 2020

12/11/2020 -

12-13 November 2020
this event is being held online

#IDIBELLconnect: Generation of protective immunity against infections by removing non-neutralizing/blocking antibodies

Rafael Máñez

Group Leader at the Bellvitge Biomedical Research Institute (IDIBELL), Innate Immunity and Pathology of the Critical Patient Group, Infectious disease and transplantation Program
Director of Intensive Care Department at Bellvitge University Hospital

20/11/2020 13:00-14:00

Microsoft Teams Meeting

Xerrades Sinergia

Òscar Martínez Tirado
Marta Barrachina
Gabriela Jiménez
Anna Veiga
Esteve Fernandez
Susana Jiménez
Rafael Máñez
Mònica Povedano
Miquel Àngel Pujana
Laia Alemany
Montse Nacher

28/11/2020 10:00-19:00

Online i en directe:

#IDIBELLconnect: The mTOR-LARP1 axis and the anabolic reservoir of tumor cells: A new therapeutic target in colorectal cancer and beyond

Antonio Gentilella

Metabolism and Cancer Group, Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL)
Department of Physiology and Biochemistry, Faculty of Pharmacy, University of Barcelona

04/12/2020 13:00-14:00

Microsoft Teams Meeting

#IDIBELLconnect: Immunotherapeutic potential of oncolytic Vaccinia viruses

Juan Jose Rojas

Bellvitge Biomedical Research Institute (IDIBELL)
Unitat d’Immunologia, Departament de Patologia i Terapèutica Experimental, Universitat de Barcelona

18/12/2020 13:00-14:00

Microsoft Teams Meeting

#IDIBELLseminars: The motivational background of addictive behaviours

Drinking motives proved to be proximate predictors of alcohol consumption and alcohol-related problems. Results revealing the importance…

Read More

“Simfonia dels herois” album presentation

The presentation of the album “Simfonia del herois” is a brain tumor research solidary musical project led…

Read More

#IDIBELLseminars: Discovering new causes of cancer through multidisciplinary, molecular and population-based approaches

Epidemiological studies to identify causes of cancer have tended to focus on individual-level exposures that can be…

Read More

#IDIBELLseminars: Regulation of cell fate and integrity by nuclear mechanotransduction

The structure of tissues is tightly linked to their function. During formation of functional organs, large-scale changes…

Read More

#IDIBELLfellows: Francesca Favaro

The UPR in cell death and inflammation in cancer Francesca Favaro Preclinical and Experimental Research in Thoracic…

Read More

#IDIBELLfellows: Mariona Chicón / Núria Gendrau

Deciphering the metastatic process of rhabdomyosarcoma: an omics approach Mariona Chicon Bosch Sarcoma Research Group    …

Read More

Thesis: The tumor microenvironment in liver metastases from colorectal cancer in the context of histologic growth patterns.

Sala d’actes Pau Viladiu 11am: Thesis: The tumor microenvironment in liver metastases from colorectal cancer in the…

Read More

Programa de actualización en Esclerosis múltiple

Programa: 11 mayo 2023 (16:30-17:30) Actualización en tratamiento para la esclerosis múltiple Ponente: Dra. Elisabet Matas Martín…

Read More

#IDIBELLExtraordinary seminars: NASH driven liver cancer: Should we target steatosis or inflammation?

The exponential increase in the consumption of refined sugar, and more specifically, high fructose corn syrup (HFCS)…

Read More

#IDIBELLseminars: UNC13A: From a SNAREopathy to Neurodegeneration

Intact communication between neurons occurs at synapses and is absolutely essential for information processing in neuronal networks….

Read More
Scroll to Top